← Leaderboards
Madhusudan Grover
Mayo Clinic Rochester
$4,489,956
Attributed
$5,569,936
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,569,936 · 5
By mechanism
R01$4,527,173 · 3
K23$804,263 · 1
R03$238,500 · 1
Top collaborators
- Gianrico Farrugia4 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Tamas Ordog$12,620,237
- Simon J Gibbons$1,049,400
- Jeong-Heon Lee$1,081,200
- Jennifer Blair McCormick$813,952
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsAffectFunctional DisorderIn VivoMediatingIntestinesExperimental StudyMicrobialSymptomsInfectionAcuteImpairmentIrritable Bowel SyndromeEnvironmentMicrobiotaIn VitroDiarrheaSourceCommunitiesPlayCampylobacter JejuniPathway InteractionsGenesBase
Grant awards (18)
Microbiota based mechanisms of post-infection irritable bowel syndrome$349,800
R01 · FY2025 · DK · contact PI
Efficacy and Safety of Proteolytic Activity-Guided fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT trial)$316,102
R01 · FY2025 · DK · contact PI
Pathophysiology of Diabetic Gastroparesis$514,330
R01 · FY2024 · DK
Microbiota based mechanisms of post-infection irritable bowel syndrome$335,808
R01 · FY2024 · DK · contact PI
Efficacy and Safety of Proteolytic Activity-Guided fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT trial)$316,102
R01 · FY2024 · DK · contact PI
Pathophysiology of Diabetic Gastroparesis$554,102
R01 · FY2023 · DK
Microbiota based mechanisms of post-infection irritable bowel syndrome$349,800
R01 · FY2023 · DK · contact PI
Pathophysiology of Diabetic Gastroparesis$552,950
R01 · FY2022 · DK
Microbiota based mechanisms of post-infection irritable bowel syndrome$349,800
R01 · FY2022 · DK · contact PI
Pathophysiology of Diabetic Gastroparesis$538,579
R01 · FY2021 · DK
Microbiota based mechanisms of post-infection irritable bowel syndrome$349,800
R01 · FY2021 · DK · contact PI
Mechanisms of barrier dysfunction in post-infection irritable bowel syndrome$119,250
R03 · FY2020 · DK · contact PI
"Barrier function alterations in post-infectious irritable bowel syndrome"$167,443
K23 · FY2019 · DK · contact PI
Mechanisms of barrier dysfunction in post-infection irritable bowel syndrome$119,250
R03 · FY2019 · DK · contact PI
"Barrier function alterations in post-infectious irritable bowel syndrome"$167,443
K23 · FY2018 · DK · contact PI
"Barrier function alterations in post-infectious irritable bowel syndrome"$167,443
K23 · FY2017 · DK · contact PI
"Barrier function alterations in post-infectious irritable bowel syndrome"$150,217
K23 · FY2016 · DK · contact PI
"Barrier function alterations in post-infectious irritable bowel syndrome"$151,717
K23 · FY2015 · DK · contact PI